<DOC>
	<DOC>NCT01520064</DOC>
	<brief_summary>- Obtain and analyze medical record data on patients with advanced emphysema who receive treatment with the AeriSeal System to better understand safety and effectiveness in the post-market setting; - Provide participating physicians access to specified data sets for the purpose of generating scientific manuscripts about the effects of AeriSeal System treatment.</brief_summary>
	<brief_title>Post Market Registry Study of the AeriSeal System</brief_title>
	<detailed_description />
	<mesh_term>Emphysema</mesh_term>
	<mesh_term>Pulmonary Emphysema</mesh_term>
	<criteria>Advanced Emphysema AeriSeal System treatment have a primary diagnosis of asthma, chronic bronchitis or bronchiectasis have had frequent COPD exacerbations within the past year require mechanical ventilatory support have a pretreatment DLCO &lt; 20% predicted or &gt; 60% predicted have a pretreatment FEV1 &lt; 20% predicted AND homogeneous emphysema have giant bullae have undergone lung transplantation, lung volume reduction surgery, or lobectomy are intolerant of corticosteroids or antibiotics are pregnant or breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Emphysema</keyword>
	<keyword>GOLD Stage III</keyword>
	<keyword>GOLD Stage IV</keyword>
	<keyword>AeriSeal System</keyword>
	<keyword>Homogeneous</keyword>
	<keyword>Heterogeneous</keyword>
	<keyword>Upper Lobe Predominant</keyword>
	<keyword>ULP</keyword>
	<keyword>Chronic Obstructive Pulmonary Disease</keyword>
	<keyword>COPD</keyword>
	<keyword>Lung Volume Reduction Surgery</keyword>
	<keyword>LVRS</keyword>
	<keyword>Bronchoscopic Lung Volume Reduction</keyword>
	<keyword>BLVR</keyword>
</DOC>